MedtecInnovation Exhibition
12month12 - 13day,2023 MedtecThe Innovation Exhibition of Medical Device Design and Manufacturing Industry was held at the Shanghai World Expo Exhibition Hall. This year's innovation exhibition focused on high-end medical device design, research and development, as well as interdisciplinary integrated innovation development.
MedtecInnovation Exhibition Convergence70Yujia has attracted many well-known enterprises from various industries such as medical manufacturing equipment, medical materials, medical components, contract manufacturing services, electronic components, assemblies, and accessories;8The grand theme forum is held during the same period.50Remaining sessions include thematic sharing, technical seminars, and R&D training. From the perspective of integrating medicine and engineering and collaborative innovation, we explore innovative technology applications such as standards and product development for Class II and III medical devices and active medical devices. Approximately10,000+Online and offline participation simultaneously. At the same time, relying onMedtec ChinaAdvantageous resources, closely interpreting policies related to foreign and domestic regulations for medical devices, quality and safety, etc., capturing new trends in innovative medical device technology, and helping enterprises seize the development opportunities of high-end medical devices "Window period" Seize the high ground of the industry.
At this event, Frost & SullivanFrost & SullivanFrost & Sullivan, abbreviated as 'Frost & Sullivan', was invited to participate in the Innovation Medical Devices Investment and Commercialization Forum. Hao Shuai, a senior consulting manager at Frost & Sullivan's Life Sciences division in Greater China, delivered a speech sharing the development path of innovative medical devices in China.
Senior Consulting Manager, Life Sciences Business Unit, Frost & Sullivan Greater China Hao Shuai
Hao Shuai pointed out that although the total market volume of medical devices in China is large, per capita consumption remains low, and compared to the global market, the market share of high-value specialized medical devices in China needs to be increased. In recent years, the state has continuously introduced favorable policies to promote the development of innovative medical devices. At the same time, the normalization of centralized procurement of medical consumables is also forcing medical device companies to achieve breakthroughs through technological innovation.
The medical device sector has received continuous capital attention, although2022The number has decreased annually, but overall, it has maintained a growth trend. A large number of investment and financing transactions are focused on the early stages.2019Year-end2023year10month31On the day, medical device investment and financing were concentrated inAPrior to this, the number of investment and financing transactions reached1,158rise. "Overall, in the primary market, investments are made early-stage startups, platforms, incubators, and niche sectors. In the secondary market, companies choose listing more diversely, placing greater emphasis on and expecting commercialization capabilities as well as their own self-sustaining abilities," said Hao Shuai.
Driven by the pandemic, domestic medical device companies have made new breakthroughs in going global in recent years. China's medical device exports have increased significantly, with in vitro diagnostic products performing particularly well. Domestic high-end medical devices have gradually gained international recognition. According to a study by Frost & Sullivan,2022Year in ChinaTop 5In addition to Jiuan Medical Devices, other medical device companies' products are mainly sold domestically. Hao Shuai believes that if domestic medical device companies want to become global leaders, they should consider overseas markets as an important strategic development layout for their enterprises.
Looking at the development of China's innovative medical device sector, in recent years, the leading tracks for medical device investment and financing have been relatively stable, with some tracks experiencing significant growth. As of2023year10month31On the same day, robotics, cardiovascular intervention, and medical imaging ranked among the top in terms of number of investment and financing transactionsTop 3, the most favored medical device sector by capital. According to Hao Shuai, the robot era is subverting various traditional surgeries and presenting development trends such as informatization, intelligence, and minimally invasive techniques; the field of cardiovascular intervention is innovating in multiple dimensions including procedures, materials, and technology; in the field of medical imaging, big data, intelligenceAIThe application trend of intraoperative image fusion technology is significant.
Finally, Hao Shuai stated that although China's medical device innovation started relatively late, it has developed rapidly. It has gradually moved from imitation-based innovation to independent innovation and expanded into international markets. In the future, China's medical devices will develop in the direction of high-endization, branding, and internationalization, with enormous development potential.
More wonderful moments from forums
About Frost & Sullivan's Life Sciences Practice
The Life Sciences Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the field of life sciences. Leveraging the global think tank resources of Frost & Sullivan and its cross-industry business development platform in Greater China, the Life Sciences Practice has unique core advantages in investment and financing services for the life sciences industry. The Life Sciences Practice has a wide range of corporate clients in China and in the past20In the year, a vast customer network was established, accumulating a wealth of project experience in various subfields of life sciences.
Project types include Knowledge Center projects (in-depth content, promotional activities).Pre-IPO financingprojectDCF modelValuation, Business Plan Services),IPO listingWe provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, and strategic consulting. We also cooperate with well-known domestic and international information platforms and investment and financing institutions, offering one-stop solutions for enterprises in specialized fields such as pharmaceuticals and medical devices. Our services have received widespread attention from investors.
